Meds & supplements › Trimipramine
Medicine
Trimipramine capsules are indicated for the relief of symptoms of depression.
Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗
Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of trimipramine capsules or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Trimipramine capsules are not approved for use in pediatric patients. (See WARNINGS - Clinical Worsening and Suicide Risk, PRECAUTIONS - Information for Patients, and PRECAUTIONS - Pediatric Use )
Trimipramine capsules are indicated for the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than other depressive states. In studies with neurotic outpatients, the drug appeared to be equivalent to amitriptyline in the less-depressed patients but somewhat less effective than amitriptyline in the more severely depressed patients.
In hospitalized depressed patients, trimipramine and imipramine were equally effective in relieving depression.
This Medication Guide has been approved by the U.S. Food and Drug Administration.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Revised: November 2025
Distributed by: Breckenridge Pharmaceutical, Inc. Berkeley Heights, NJ 07922
Manufactured by: Rivopharm SA 6928, Manno, Switzerland
sofidex [Internet]. Daloreum; c2026. Trimipramine; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/trimipramine
sofidex. (2026, August 2). Trimipramine. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/trimipramine
Trimipramine. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/trimipramine
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.